IRIS
GANDOLFO, CLAUDIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.882
NA - Nord America 2.562
AS - Asia 1.228
SA - Sud America 250
AF - Africa 37
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
Totale 6.965
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.524
RU - Federazione Russa 733
IT - Italia 533
IE - Irlanda 494
SG - Singapore 488
GB - Regno Unito 383
CN - Cina 322
BR - Brasile 205
SE - Svezia 181
DE - Germania 147
HK - Hong Kong 112
FI - Finlandia 106
FR - Francia 98
VN - Vietnam 90
UA - Ucraina 61
KR - Corea 52
IN - India 51
PL - Polonia 27
ES - Italia 25
NL - Olanda 21
BE - Belgio 19
TR - Turchia 18
CA - Canada 17
MX - Messico 14
BD - Bangladesh 12
AR - Argentina 11
AT - Austria 11
PK - Pakistan 11
CI - Costa d'Avorio 10
IQ - Iraq 10
JP - Giappone 10
ZA - Sudafrica 10
IM - Isola di Man 9
CO - Colombia 8
CZ - Repubblica Ceca 8
ID - Indonesia 7
AE - Emirati Arabi Uniti 6
PE - Perù 6
EC - Ecuador 5
IL - Israele 5
MA - Marocco 5
UZ - Uzbekistan 5
BG - Bulgaria 4
CL - Cile 4
IR - Iran 4
LT - Lituania 4
MT - Malta 4
PY - Paraguay 4
DZ - Algeria 3
EU - Europa 3
JO - Giordania 3
SA - Arabia Saudita 3
TH - Thailandia 3
UY - Uruguay 3
VE - Venezuela 3
AL - Albania 2
CH - Svizzera 2
DO - Repubblica Dominicana 2
EG - Egitto 2
KE - Kenya 2
KZ - Kazakistan 2
NP - Nepal 2
PH - Filippine 2
PT - Portogallo 2
RO - Romania 2
TN - Tunisia 2
AM - Armenia 1
AO - Angola 1
AU - Australia 1
BO - Bolivia 1
BY - Bielorussia 1
CR - Costa Rica 1
EE - Estonia 1
GE - Georgia 1
HN - Honduras 1
HU - Ungheria 1
JM - Giamaica 1
KG - Kirghizistan 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LU - Lussemburgo 1
MK - Macedonia 1
MU - Mauritius 1
MY - Malesia 1
NG - Nigeria 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
PW - Palau 1
QA - Qatar 1
TT - Trinidad e Tobago 1
Totale 6.965
Salva come PNG Salva come JPEG
Città #
Dublin 479
Dallas 322
Southend 308
Singapore 307
Ashburn 225
Chandler 218
Fairfield 204
Moscow 204
Santa Clara 175
Siena 164
Hong Kong 111
Beijing 104
Wilmington 91
Ann Arbor 75
Houston 75
Woodbridge 74
Cambridge 71
New York 70
Seattle 69
Princeton 68
Helsinki 63
Munich 58
Milan 56
Jacksonville 52
Los Angeles 52
Seoul 50
Rome 40
Hefei 39
Florence 33
The Dalles 30
Fremont 27
Warsaw 26
Dong Ket 25
Menlo Park 24
Ho Chi Minh City 21
San Mateo 17
Shanghai 17
São Paulo 17
Turku 17
Brussels 16
Buffalo 15
Boardman 14
Hanoi 14
Málaga 14
Lauterbourg 13
Nanjing 13
Redondo Beach 13
San Diego 13
Lappeenranta 12
Lancaster 11
Nuremberg 11
Abidjan 10
Düsseldorf 10
London 10
Montreal 10
Portsmouth 10
Chennai 9
Columbus 9
Dearborn 9
Falls Church 9
Frankfurt am Main 9
Tokyo 9
Chicago 8
Council Bluffs 8
Douglas 8
Izmir 8
Atlanta 7
Bengaluru 7
Boston 7
Karlsruhe 7
Messina 7
Poplar 7
Rio de Janeiro 7
Shenyang 7
Denver 6
Espoo 6
Norwalk 6
Phoenix 6
Stockholm 6
Vienna 6
Ankara 5
Falkenstein 5
Orem 5
Poli 5
Tashkent 5
Washington 5
Brooklyn 4
Cagliari 4
Campofilone 4
Dubai 4
Guangzhou 4
Guarulhos 4
Hebei 4
Istanbul 4
Manchester 4
Marano Di Napoli 4
Massa 4
Mexico City 4
Modena 4
Mumbai 4
Totale 4.551
Salva come PNG Salva come JPEG
Nome #
A Respiratory Syncytial Virus Vaccine Vectored by a Stable Chimeric and Replication-Deficient Sendai Virus Protects Mice without Inducing Enhanced Disease 349
Phase Ib study of poly-epitope peptide vaccination to thymidylate synthase (TSPP) and GOLFIG chemo-immunotherapy for treatment of metastatic colorectal cancer patients 312
Systemic inflammatory status predict the outcome of k-RAS WT metastatic colorectal cancer patients receiving the thymidylate synthase poly-epitope-peptide anticancer vaccine 298
Immune-modulating effects of bevacizumab in metastatic non-small-cell lung cancer patients 251
Phase I trial of thymidylate synthase poly-epitope peptide (TSPP) vaccine in advanced cancer patients 249
Antibody response to SARS-CoV-2 in infected patients with different clinical outcome 243
PD-1/PD-L1 immune-checkpoint blockade induces immune effector cell modulation in metastatic non-small cell lung cancer patients: A single-cell flow cytometry approach 241
Radiotherapy prolongs the survival of advanced non-small-cell lung cancer patients undergone to an immune-modulating treatment with dose-fractioned cisplatin and metronomic etoposide and bevacizumab (mPEBev). 234
Host-pathogen interaction: study of Toscana virus 227
Whole-Genome Sequence of SARS-CoV-2 Isolate Siena-1/2020 220
Overview of Anti-SARS-CoV-2 Immune Response Six Months after BNT162b2 mRNA Vaccine 200
Immune-inflammatory markers predict the outcome of metastatic colorectal cancer patients treated with the thymidylate synthase poly-epitope peptide (TSPP) vaccine: results from a multi-arm TSPP/VAC phase lb program 189
Identification of a neutralizing epitope on tosv gn glycoprotein 188
Seroprevalence to measles virus after vaccination or natural infection in an adult population, in Italy 186
Infection prevention in endoscopy practice; comparative evaluation of reusable vs single use endoscopic valves 170
Omicron infection evokes cross-protection against SARS-CoV-2 variants in vaccinees 165
Detection of asymptomatic SARS-CoV-2 infections among healthcare workers: Results from a large-scale screening program based on rapid serological testing 163
SARS-CoV-2 Antibody Response in Persons with Past Natural Infection 161
Toscana virus non-structural protein NSs acts as E3 ubiquitin ligase promoting RIG-I degradation 157
Alcohol intake and the risk of intracerebral hemorrhage in the elderly: The MUCH-Italy 156
Ubiquitin and not only unfolded domains drives toscana virus non-structural NSs protein degradation 155
Human Polymorphonuclear Cells Support Zika Virus to Cross Endothelial Monolayer and Access Bloodstream 153
Infectious Toscana virus in seminal fluid of young man returning from Elba Island, Italy 152
Neutralizing antibody response of vaccinees to SARS-CoV-2 variants 151
Efficient inactivation of sars-cov-2 and other rna or dna viruses with blue led light 149
Comparative performance of a new sars-cov-2 rapid detection system 149
Rational Use of Monoclonal Antibodies as Therapeutic Treatment in an Oncologic Patient with Long COVID 145
Hepatitis C Virus Core Antigen (HCVAg): an affordable assay to monitor the efficacy of treatment in DAAs era 145
How long can SARS-CoV-2 persist in human corpses? 144
SARS-CoV-2 infection in cancer patients on active therapy after the booster dose of mRNA vaccines 143
Epidemiology of Toscana virus in South Tuscany over the years 2011-2019 139
Residual SARS-CoV-2 RNA in nasal swabs of convalescent COVID-19 patients: Is prolonged quarantine always justified? 129
Toscana virus infects dendritic and endothelial cells opening the way for the central nervous system 128
Hyperimmune plasma in three immuno-deficient patients affected by non-severe, prolonged COVID-19: a single-center experience 124
Antibody Response against Circulating Omicron Variants 8 Months after the Third Dose of mRNA Vaccine 115
Nucleopore Traffic Is Hindered by SARS-CoV-2 ORF6 Protein to Efficiently Suppress IFN-β and IL-6 Secretion 110
null 103
Severe acute respiratory syndrome coronavirus 2 vaccination and cancer therapy: A successful but mindful mix 103
Detection of SARS-CoV-2 N protein allelic variants by rapid high-throughput CLEIA antigen assay 89
Validation of Two Commercial Multiplex Real-Time PCR Assays for Detection of SARS-CoV-2 in Stool Donors for Fecal Microbiota Transplantation 81
SARS-CoV-2 n protein targets TRIM25-mediated RIG-I activation to suppress innate immunity 81
Truncation of the C-terminal region of Toscana Virus NSs protein is critical for interferon-β antagonism and protein stability 74
Totale 7.121
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.292
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.292
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021502 0 0 0 0 0 103 77 57 58 83 39 85
2021/2022529 34 33 24 39 23 27 21 16 99 45 57 111
2022/2023758 42 92 98 80 75 154 18 74 59 25 25 16
2023/2024862 24 51 70 47 35 212 307 24 7 14 16 55
2024/20251.440 57 61 158 94 163 98 94 94 160 80 157 224
2025/20262.114 228 383 282 460 733 28 0 0 0 0 0 0
Totale 7.121